Armata Pharmaceuticals Files Proxy Statement for June 12 Meeting
Ticker: ARMP · Form: DEF 14A · Filed: Apr 28, 2025 · CIK: 921114
| Field | Detail |
|---|---|
| Company | Armata Pharmaceuticals, INC. (ARMP) |
| Form Type | DEF 14A |
| Filed Date | Apr 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Armata Pharma proxy filed, shareholder vote on directors & auditors June 12.
AI Summary
Armata Pharmaceuticals, Inc. filed its definitive proxy statement on April 28, 2025, for its annual meeting of stockholders scheduled for June 12, 2025. The filing outlines the proposals to be voted on by shareholders, including the election of directors and the ratification of the appointment of its independent registered public accounting firm. The company, formerly known as AmpliPhi Biosciences Corp and Targeted Genetics Corp, is focused on biological products.
Why It Matters
This filing provides shareholders with crucial information to make informed voting decisions on company leadership and financial oversight, impacting the company's strategic direction.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual shareholder meeting, not indicating immediate financial distress or significant new risks.
Key Players & Entities
- Armata Pharmaceuticals, Inc. (company) — Registrant
- June 12, 2025 (date) — Annual Meeting Date
- April 28, 2025 (date) — Filing Date
- AmpliPhi Biosciences Corp (company) — Former Company Name
- Targeted Genetics Corp (company) — Former Company Name
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the annual meeting of stockholders on June 12, 2025, including proposals for voting such as the election of directors and ratification of the independent auditor.
When was this proxy statement filed with the SEC?
This definitive proxy statement was filed with the SEC on April 28, 2025.
What are the former names of Armata Pharmaceuticals, Inc.?
Armata Pharmaceuticals, Inc. was formerly known as AmpliPhi Biosciences Corp and prior to that, Targeted Genetics Corp /WA/.
What is the business address of Armata Pharmaceuticals, Inc.?
The business address is 5005 McConnell Ave, Los Angeles, CA 90066.
What is the SIC code for Armata Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Armata Pharmaceuticals, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 28, 2025 regarding Armata Pharmaceuticals, Inc. (ARMP).